Herein, we find that ICC/IDC cancer cell heterogeneity is most notably governed by individual patient gene expression as opposed to commonly altered oncogenic pathways, including prostate cancer drivers like ERG and PTEN. The gene discussed is PTEN; the disease is prostate carcinoma.